Funded Britain
UK tech & science funding · 2024

For every £100 of UK venture funding in 2024, all-female founding teams received £2.

Where UK tech and science money flows, and who it leaves behind.

The numbers below trace £88 billion across the four sources that fund UK research and innovation, into the sectors they back, and onward to the people who actually receive the cheques.

Scroll to see the flow, drill into each source, toggle the lens, and read the methodology.
The argument

£88 billion is a fact. It is not yet a story.

Funded Britain is a personal investigation by Serene Lim into how UK research and innovation funding actually moves, who it reaches, and what the headline numbers leave out. It is independent, not affiliated with any institution, and intended to be read as an argument from a single point of view rather than a neutral report.

Every year the UK reports a new headline number for the money flowing into research and innovation, and every year a fresh set of arguments follows about why the country is not doing better. The two are rarely connected, because the numbers stay abstract. £88 billion is a quantity, not an explanation.

This site exists to make that quantity legible. Where it comes from, what it touches, and who eventually receives the cheque. The headline disparity above — £2 of every £100 of UK venture funding reaching all-female founding teams — is one finding among many. Underneath it sit harder questions. Is the system correcting itself? How does the UK compare with its peers? Are the sectors attracting most capital reproducing the pattern or breaking it?

The current argument about UK and European tech rests largely on a confidence diagnosis: that ambitious people need to believe Europe can build serious companies and that activity will follow. This site asks whether confidence built on a system that distributes capital this unevenly might produce more uneven activity, only more loudly performed. The harder question is what gets measured, what is missed, and who remains invisible inside an £88 billion economy that is still mostly invisible to its own participants.

The flow

Four sources. Four sectors. Three lenses on who got the money.

The Sankey traces capital from where it originates (left) through the sectors it enters (middle) to the demographic profile of the founders and recipient teams (right). Toggle the right-hand column to switch the lens.

View
Demographic lens
Note on the right-hand column: Demographic data on UK funding recipients is reliably tracked only for venture capital (£9bn of the £88bn total). Government and corporate R&D flow primarily to institutions and large corporates where founder demographics are not the relevant unit of analysis. The right-hand column therefore breaks down VC recipients only, scaled to the £9bn VC slice.

Source figures in £ billions. Sectors simplified for legibility. Hover any flow to see the full value. Right-hand column: gender breakdown of VC recipient teams.

Anatomy of the £88 billion

What's actually inside each of the four sources?

Each source is a category, not a single thing. The boxes below open up what the money actually consists of, where it lands, and what is and isn't tracked about who receives it.

£20.4bn

Government R&D

Public money for research, allocated through agencies and departments. Mostly flows to universities and research councils, with a meaningful slice for defence research.

What's in it:
  • UK Research and Innovation (UKRI), excluding Research England — £6.8bn (33%)
  • Higher education funding bodies (QR funding to universities) — £3.4bn
  • Civil departments (DSIT, DHSC, DEFRA, DfT, etc) — £5.8bn
  • Ministry of Defence research — £3.1bn
  • UK contribution to Horizon Europe and Copernicus — £1.2bn
Who receives it:
  • UK universities (the bulk, via UKRI grants and QR funding to Russell Group institutions)
  • Research councils' own labs and institutes (e.g. UKAEA, NPL)
  • Defence research labs (Dstl) and contracted defence companies
  • Innovate UK grants to specific UK companies (~£1bn/year)
Demographic data: limited. UKRI publishes equality and diversity data on grant applicants and recipients, but it is not aggregated into the kind of founder-level breakdown VC has.
£55.6bn

Business R&D

R&D performed by UK businesses, mostly funded out of their own balance sheets. Money the company spends on its own scientists, engineers, and labs, plus government and overseas top-ups.

What's in it:
  • Companies' own funds (the dominant source, ~70%): salaries, lab costs, equipment, software development
  • HMRC R&D tax credits (a tax expenditure, not direct funding, but reduces effective cost)
  • Innovate UK and other government grants to businesses
  • Overseas funding (multinationals' UK subsidiaries funded from parent)
Who receives it:
  • Large companies dominate: 68% of business R&D, 32% from SMEs
  • Top performers concentrated in pharmaceuticals (AstraZeneca, GSK), defence (BAE Systems), automotive (JLR, Rolls-Royce), and big tech UK arms
  • Software development is the single largest activity at £10.3bn (18.5%)
  • Geographically concentrated: London £13.3bn, East of England £10.3bn, South East £9.2bn
Demographic data: not tracked at the recipient level. The "founding team" frame doesn't apply to a 50,000-person pharmaceutical multinational.
£9.0bn

Venture Capital

Equity investment into UK startups and scaleups, deployed by VC funds, corporate investors, and financial institutions. The smallest of the four sources, but the only one where founder demographics are reliably tracked.

What's in it:
  • Seed-stage rounds (under £2m typically) — sharply up in 2024
  • Series A through C rounds (the bulk of value)
  • Late-stage and growth rounds (£100m+) — over 60% of late-stage capital comes from overseas, mostly the US
  • Corporate venture capital arms (~16% of deals)
Who receives it:
  • Greater London: 60% of investment value, 47% of deals
  • Cambridge and Oxford spinouts: £2.6bn in equity in 2024
  • Sector concentration: AI alone attracted £1.8bn in H1 2024
  • Notable 2024 raises: Wayve ($1.05bn autonomous driving), Monzo ($431m), Apollo Therapeutics ($260m)
Demographic data: well tracked. The disparity numbers above the Sankey come from this slice.
£3.0bn

Science philanthropy

Charitable funding for research, dominated by medical research charities. Largely funds direct project costs in UK universities; collectively the largest funder of medical research in the UK.

What's in it:
  • AMRC medical research charities (148 organisations) — £1.6bn collective spend in 2024-25
  • Wellcome Trust — the single largest UK medical research funder (~£1.6bn annual)
  • Cancer Research UK — over £600m annual research expenditure
  • British Heart Foundation, Alzheimer's Research UK, Versus Arthritis, and 145 other charities
  • ARIA (Advanced Research and Invention Agency) — ~£200m/year programmes
  • Royal Society and learned academies — smaller programme funding
Who receives it:
  • UK universities host 87% of AMRC charity-funded research
  • Major medical research institutes (Francis Crick Institute, MRC institutes)
  • NHS hospitals running clinical trials
  • Specific researchers via fellowships (Wellcome Early-Career, CRUK Fellowships, etc)
Demographic data: variable. Wellcome publishes detailed equality and diversity data on its grants; many smaller charities do not.
The UK in context

The UK is best-in-class of a class that systemically undercounts women.

On the most-cited diversity metric in venture capital — the share of total invested capital reaching all-female founding teams — no major Western VC ecosystem performs materially better than any other. The cross-country data is consistent enough that this finding holds across the major reporting bodies (BBB, PitchBook, Sifted) at the value level, even where deal-count metrics tell a more nuanced story. The honest finding is not that the UK trails its peers, but that no Western VC ecosystem is moving the number.

Sources: PitchBook All In: Female Founders in the European VC Ecosystem (2023, 2024); British Business Bank Small Business Equity Tracker; Sifted analysis. All figures are share of VC investment by value to all-female founding teams, latest available year (2023 or 2024 depending on jurisdiction). Deal-count shares (not shown) tell a different story; in the US deal counts to all-female teams reach 5.4%, but capital value remains close to 2%.

The European response to American tech dominance has been a series of confidence campaigns. The numbers underneath the confidence are essentially identical across the Western VC world.
The AI question

AI is now the largest single sector in UK venture capital. It is also materially less diverse than the average.

In the first half of 2024 alone, UK AI startups attracted £1.8 billion of venture capital. The Alan Turing Institute's Rebalancing Innovation report tracked who received the AI cheques over the preceding decade. The pattern is consistent: AI is significantly worse than the all-sector UK VC average on every gender metric tracked.

0.3%
vs 2.0%
across all UK VC
UK AI venture capital reaching all-female founding teams (2012–2022 average).
Of the £55 billion deployed by UK VCs into AI startups over the decade, £200 million went to all-female-founded companies. The remainder split between all-male and mixed-gender teams.
Alan Turing Institute, Rebalancing Innovation (2023)
6.6×
vs
across all UK VC
Per-deal capital gap between all-male and all-female AI founding teams.
Average all-male AI deal: £8.6 million. Average all-female AI deal: £1.3 million. The deal-size gap in AI is materially worse than across UK VC generally.
Alan Turing Institute, Rebalancing Innovation (2023)
95.5%
of AI deals
UK AI funding rounds made by VC firms with majority-male decision-makers.
Only 5% of VCs participating in AI deals over the decade had equal or majority female representation in their investment teams. The decision layer reproduces itself in the recipient layer.
Alan Turing Institute, Rebalancing Innovation (2023)
£1.8bn
H1 2024
UK AI VC
UK AI venture funding in the first six months of 2024.
AI is now the largest single sector within UK VC, ahead of fintech and life sciences. Notable 2024 raises included Wayve ($1.05bn for autonomous driving), Synthesia, and PolyAI.
Dealroom UK AI report 2024
The sector now attracting the largest share of UK risk capital is reproducing existing distributional patterns at a more concentrated scale. The decisions being made by VCs in 2024–26 will compound for a decade.
The counterfactual

If UK venture funding looked like the country, the founder pool, or the PhD pool — what would change?

There is no single "right" benchmark. Three different baselines tell three different stories. We show all three.

Compare against
Patterns the data reveals

Six things the numbers tell us.

Drawn directly from the underlying datasets, not selected to support a thesis.

13 vs 3,700
Black women who received UK venture funding 2019–2023, against white men who did.
Black founders' share of UK VC peaked at 1.13% in 2021 during the post–George Floyd reckoning, and has since fallen back to 0.95% in 2023. Black women's share over the same period: 0.02%.
Extend Ventures, Diversity Beyond Gender UK 2023; CNBC analysis 2025
11% → 18%
Share of VC rounds going to Global Majority Heritage founders versus their share of the UK population.
Black, East Asian, Middle Eastern and South Asian founders are underrepresented relative to population, and raise smaller rounds when they do.
Extend Ventures, Diversity Beyond Gender UK (2023)
40%
Share of seed-stage UK VC going to founders with elite educations.
Defined as at least one team member from Oxford, Cambridge, Harvard or Stanford. The funnel narrows further at Series A.
Extend Ventures (2020); cited British Business Bank (2024)
5.9×
Average early-stage VC raised by male founders relative to female founders.
Even when women secure funding, the cheque is materially smaller. Average all-male deal: £11.7m. Average all-female deal: £5.2m.
Founders Forum / Burges Salmon analysis (2024)
2065
The year UK VC reaches gender parity at current rates of improvement.
For all-female teams to reach even 10% of UK VC deals, the British Business Bank projects another 20+ years of progress at current pace.
British Business Bank, UK VC & Female Founders
£250bn
Estimated economic value the UK could unlock by closing the gender entrepreneurship gap.
Equivalent to one million additional SME businesses, per the Rose Review. The cost of inaction has a price tag.
HM Treasury / Alison Rose Review of Female Entrepreneurship
Methodology & sources

Every number on this page is sourced. Here is exactly how it was assembled.

Scope

UK tech and science funding, calendar year 2024 where available, financial year 2024-25 for government R&D. We include four sources of capital: government R&D spending, business-funded R&D, venture capital invested into UK startups and scaleups, and major UK science philanthropy.

Funding source figures

  • Government R&D — £20.4bn: Office for National Statistics, "Research and development expenditure by the UK government 2024" (released April 2026). Includes UKRI (£6.8bn), civil departments (£5.8bn), higher education funding bodies (£3.4bn), MOD (£3.1bn), Horizon Europe and Copernicus contributions (£1.2bn). ONS
  • Business R&D — £55.6bn: ONS Business Enterprise Research and Development (BERD) 2024. Measures R&D performed by UK businesses, mostly funded from their own balance sheets, with smaller contributions from Innovate UK grants, HMRC R&D tax credits, and overseas funds. 68% from large companies, 32% from SMEs. ONS
  • Venture capital — £9bn: British Private Equity & Venture Capital Association, Venture Capital in the UK 2025 report. Includes investment by VC funds, co-investors, and financial institutions into UK startups and scaleups. BVCA
  • Science philanthropy — £3bn (estimate): Aggregated estimate based on Association of Medical Research Charities collective spend (£1.6bn in 2024-25 across 148 charities), Wellcome Trust (~£1.6bn annual research funding), ARIA programme spend (~£200m/year), plus Royal Society and other research charities. AMRC 2025

Sector allocation

Sectors are simplified into four buckets — Software & AI, Life Sciences & Health, Energy & Climate, Other Tech & Industrial — to keep the diagram legible. Allocations are based on ONS BERD sector breakdowns, BVCA / Dealroom sector data for VC, and UKRI portfolio breakdowns for government. Software & AI is the single largest sector across both VC and business R&D in 2024, with AI alone attracting an estimated £1.8bn of UK VC in H1 2024.

Demographic data

Founder demographic data is drawn from:

  • Gender: British Business Bank Small Business Equity Tracker; Investing in Women Code Annual Report 2024. All-female teams: ~2% of VC value. Mixed-gender teams: ~13%. All-male teams: ~85%.
  • Ethnicity: Extend Ventures, Diversity Beyond Gender (2020) and Diversity Beyond Gender UK 2023; British Business Bank Small Business Equity Tracker. Disaggregated shares (directional): All-white teams ~74%; Mixed teams ~21.5%; South Asian-led teams ~2.5%; East Asian-led teams ~1.5%; Black-led teams ~0.5%. Black founders received 0.95% of VC investment value in 2023; only 13 Black women received venture funding between 2019 and 2023, against 3,700+ white men.
  • Age: Data is patchier than for gender or ethnicity. Estimates here are derived from Beauhurst founder profiles and Atomico State of European Tech surveys, with all the caveats that implies. Treat as directional, not definitive.

Demographic flows in the Sankey are applied only to the £9bn venture capital slice. Government and corporate R&D flow primarily to institutions and large corporates where founder demographics are not the relevant unit of analysis (the Anatomy section above explains who the actual recipients are).

Counterfactual benchmarks

The "what if" section compares actual VC allocation against three benchmarks, each with its own assumption:

  • Population-proportional: assumes funding should mirror UK population demographics (50.6% female; ~18% Global Majority Heritage per the 2021 Census).
  • Founder-pool-proportional: assumes funding should mirror the demographic mix of UK entrepreneurs (~33% female; ~14% ethnic minority among UK SME founders per BEIS Longitudinal Small Business Survey).
  • PhD-pool-proportional: assumes funding should mirror the demographic mix of UK PhD holders in STEM (~46% female; ~22% non-white per HESA).

None of these benchmarks is "the right one". They are presented together so readers can choose their own frame of reference.

Trends, peer comparison, and AI deep-dive

The trends, peer comparison, and AI sections draw on:

  • Trends 2015–2024: British Business Bank, UK VC & Female Founders (2019) and Small Business Equity Tracker (annual, 2019–2024); Extend Ventures, Diversity Beyond Gender (2020) and Diversity Beyond Gender UK (2023); Equidam, UK Startup Funding 2025: A Guide for Early-Stage Founders; Parliament Women and Equalities Committee report on Female Entrepreneurship (2025). The 2009–2019 Black founder figure is plotted as a period average; subsequent years use Extend Ventures' year-on-year data where published.
  • Peer comparison: PitchBook, All In: Female Founders in the European VC Ecosystem (2023, 2024); Sifted analyses; British Business Bank for UK figures. All figures are share of VC investment by value to all-female founding teams in latest reported year. Comparisons use the most directly comparable methodology each source supports; small differences in definition (founding team vs lead founder; first-time deal vs all rounds) are noted in the original reports.
  • AI deep-dive: Alan Turing Institute, Rebalancing Innovation: Women, AI and Venture Capital in the UK (Wajcman, Young, De Miguel Velazquez, 2023) and Second Report (Wajcman, Young, Kampmann, 2024). Decade covered: 2012–2022. H1 2024 figure is from Dealroom UK AI 2024 reporting. Notable raises drawn from public coverage of 2024 funding rounds.

Notes on the data

Numbers are rounded to one decimal place for legibility. Year-over-year comparisons should rely on the linked primary sources, not on the figures shown here. Sectors are simplified into four buckets to keep the diagram legible. Demographic flows in the Sankey are applied only to the £9bn venture capital slice for the reasons set out above. The intention is to make the shape of the problem visible, with full transparency on inputs.

Scope and limits

This site focuses on the value-share metric because it is the most consistently reported across jurisdictions and the most directly tied to where capital actually lands. Deal-count metrics, founder-pipeline metrics, and exit-value metrics tell related but distinct stories, and a fuller account would weigh each against the others.

The other significant omission is qualitative: this site has no founder interviews, no investor interviews, and no case studies of the teams that did break through despite the patterns shown here. That work is being done well by others. Extend Ventures' Diversity Beyond Gender reports pair quantitative analysis with the lived experience of underrepresented founders. Diversity VC's Equity Record combines pipeline data with qualitative survey work on investor culture. The Alan Turing Institute's Rebalancing Innovation series includes founder and investor interviews alongside the AI funding analysis cited above. The most useful version of this site sits alongside that work rather than competing with it.